MIJA, L. A.; ELKRIEF, A. Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Canadian Oncology Today, [S. l.], v. 2, n. 1, p. 13–17, 2025. DOI: 10.58931/cot.2025.2131. Disponível em: https://canadianoncologytoday.com/article/view/2-1-Mija_et_al. Acesso em: 13 jun. 2025.